Devices and methods for predicting and preventing restenosis
First Claim
1. A device for determining an enhanced risk of restenosis in an arterial tissue, the device comprising:
- an imaging catheter having a sensor configured to image a portion of an artery;
a processor configured to receive images of the artery from the sensor and to detect regions of hypercellularity in the artery by counting or estimating the amount of satellite-to-spindle shaped smooth muscle cells within stroma in the received images, and further configured to detect regions of either or both;
lipid-rich tissue and inflammatory cells in the artery from the received images; and
a display configured to display a modified view of the artery indicating hypercellularity and the one or both of lipid-rich tissue and inflammatory cells in the artery.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to methods and devices for predicting restenosis, and for treating atherosclerosis to prevent or reduce the incidence of restenosis. Methods of predicting restenosis in a stenosed peripheral artery may include quantitative histology of the vessel. For example, a method of treating a stenosed artery (and particularly a peripheral artery) may include the steps of determining a level of hypercellularity and one or more of the lipid-richness and extent of inflammatory cell inclusion in the tissue. An index of restenosis based on the hypercellularity and lipid richness and/or extent of inflammatory cell inclusion in the tissue may be determined. Systems for treating or preventing restenosis may include one or more imaging modalities for imaging tissue regions and determining the level of hypercellularity and one or more of the degree of lipid-richness and the extent of inflammatory cell inclusion in the tissue region.
-
Citations
29 Claims
-
1. A device for determining an enhanced risk of restenosis in an arterial tissue, the device comprising:
-
an imaging catheter having a sensor configured to image a portion of an artery; a processor configured to receive images of the artery from the sensor and to detect regions of hypercellularity in the artery by counting or estimating the amount of satellite-to-spindle shaped smooth muscle cells within stroma in the received images, and further configured to detect regions of either or both;
lipid-rich tissue and inflammatory cells in the artery from the received images; anda display configured to display a modified view of the artery indicating hypercellularity and the one or both of lipid-rich tissue and inflammatory cells in the artery. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. A system for indicating an enhanced risk of restenosis in an arterial tissue, the system comprising:
-
an imaging modality configured to image a region of arterial tissue; and a processor configured to receive the image of the region of arterial tissue from the imaging modality and to determine a measure of hypercellularity by counting or estimating the amount of satellite-to-spindle shaped smooth muscle cells within stroma and further configured to determine one or both of;
a measure of how lipid-rich the tissue region is and a measure of how many inflammatory cells there are associated with the tissue region; andindex logic configured to determine an index of restenosis for the tissue region based on the measure of hypercellularity and one or both of the measures of how lipid-rich the first tissue region is and the measure of how many inflammatory cells are associated with the first tissue region. - View Dependent Claims (12, 13)
-
-
14. A method of determining an enhanced risk of restenosis in an arterial tissue, the method comprising:
-
determining a measure of hypercellularity in a first arterial tissue region by counting or estimating the amount of satellite-to-spindle shaped smooth muscle cells within stroma; determining one or both of;
a measure of how lipid-rich the first tissue region is and a measure of how many inflammatory cells there are associated with the first tissue region;determining an index of restenosis for the first tissue region based on the measure of hypercellularity and one or both of the measures of how lipid-rich the first tissue region is and the measure of how many inflammatory cells are associated with the first tissue region; and presenting the index of restenosis for the first tissue region. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
-
25. A method of preventing restenosis in an arterial tissue, the method comprising:
-
determining an index of restenosis for a first arterial tissue region based on a measure of hypercellularity of the first arterial tissue region, the measure of hypercellularity based upon counting or estimating the amount of satellite-to-spindle shaped smooth muscle cells within stroma, and one or both of a measure of how lipid-rich the first arterial tissue region is and a measure of how many inflammatory cells are associated with the first arterial tissue region; and inserting a stent adjacent to the first arterial tissue region when the index of restenosis indicates a greater likelihood of restenosis. - View Dependent Claims (26, 27)
-
-
28. A device for determining an enhanced risk of restenosis in an arterial tissue, the device comprising:
-
an imaging catheter having a sensor configured to image a portion of an artery; a processor configured to receive images of the artery from the sensor and to detect regions of hypercellularity in the artery based on a presence of satellite-to-spindle shaped smooth muscle cells within stroma in the received images, and further configured to detect regions of either or both;
lipid-rich tissue and inflammatory cells in the artery from the received images; anda display configured to display a modified view of the artery indicating hypercellularity and the one or both of lipid-rich tissue and inflammatory cells in the artery.
-
-
29. A method of determining an enhanced risk of restenosis in an arterial tissue, the method comprising:
-
determining a measure of hypercellularity in a first arterial tissue region by identifying satellite-to-spindle shaped smooth muscle cells within stroma; determining one or both of;
a measure of how lipid-rich the first tissue region is and a measure of how many inflammatory cells there are associated with the first tissue region;determining an index of restenosis for the first tissue region based on the measure of hypercellularity and one or both of the measures of how lipid-rich the first tissue region is and the measure of how many inflammatory cells are associated with the first tissue region; and presenting the index of restenosis for the first tissue region.
-
Specification